ArticleBMC gastroenterology2026

Real-world outcomes of tumour necrosis factor inhibitor (TNFi) cyclers versus mechanism-of-action switchers among ulcerative colitis patients who failed first-line TNFi.

Navneet Upadhyay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.